Filter your results
- 2
- 2
- 4
- 4
- 2
- 1
- 1
- 4
- 4
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma.Cancer, 2010, 116 (4 Suppl), pp.1053-8. ⟨10.1002/cncr.24792⟩
Journal articles
hal-00930166v1
|
|||
|
Tumor Immunotargeting Using Innovative RadionuclidesInternational Journal of Molecular Sciences, 2015, 16 (2), pp.3932 - 3954. ⟨10.3390/ijms16023932⟩
Journal articles
inserm-01818715v1
|
||
¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 (8), pp.1501-1510
Journal articles
hal-01111285v1
|
|||
|
A pretargeting system for tumor PET imaging and radioimmunotherapyFrontiers in Pharmacology, 2015, 6, pp.54. ⟨10.3389/fphar.2015.00054⟩
Journal articles
inserm-02913677v1
|